2026
article
OpenAlex
Alissa O’Halloran, Nicole Hood, Dawud Ujamaa, Angiezel Merced-Morales et autres
BACKGROUND: Older individuals (≥65 years) are at greatest risk of severe influenza requiring hospitalization. Since 2009, influenza-associated hospitalization rates during A(H1N1)pdm09-predominant influenza seasons have been lower than during A(H3N2) -predominant seasons. \. METHODS: Using laboratory-confirmed influenza hospitalization rates from U.S. population-based surveillance, …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Amara Fazal, Elizabeth J. Harker, Varsha Neelam, Samantha M. Olson et autres
In January 2025, CDC received several reports of deaths among children aged <18 years with a severe form of influenza-associated encephalopathy (IAE) termed acute necrotizing encephalopathy (ANE). Because no national surveillance for IAE currently exists, CDC requested notification of U.S. pediatric IAE …
mn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Alissa C. O’Halloran, Jennifer Whitmill Habeck, Matthew S. Gilmer, Ryan Threlkel et autres
The U.S. 2024-25 influenza season was a high-severity season characterized by co-circulation of influenza A(H1N1)pdm09 and A(H3N2) viruses. Data from the Influenza Hospitalization Surveillance Network covering 9% of the U.S. population, were analyzed to compare laboratory-confirmed influenza-associated hospitalization rates and patient clinical …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Monica E. Patton, Heidi L. Moline, MICHAEL D. WHITAKER, Ayzsa F. Tannis et autres
Maternal respiratory syncytial virus (RSV) vaccine and nirsevimab, a long-acting monoclonal antibody for infants aged 0-7 months and children aged 8-19 months who are at increased risk for severe RSV disease, became widely available for prevention of severe RSV disease among infants …
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Zachary J. Madewell, Kelly Charniga, Nina B. Masters, Jason Asher et autres
Using data from 12 US health departments, we estimated mean serial interval for monkeypox virus infection to be 8.5 (95% credible interval 7.3-9.9) days for symptom onset, based on 57 case pairs. Mean estimated incubation period was 5.6 (95% credible interval 4.3-7.8) …
us, se, gb
(code pays fourni par la source)
Accès ouvert
2022
preprint
OpenAlex
Zachary J. Madewell, Kelly Charniga, Nina B. Masters, Jason Asher et autres
Abstract Using data collected by 12 U.S. health departments, we report mean estimated serial interval for monkeypox virus infection of 8.5 (95% CrI: 7.3 – 9.9) days for symptom onset from 57 case pairs and mean estimated incubation period of 5.6 (4.3 …
us, sk
(code pays fourni par la source)